20/20 Capital Management’s Pfizer PFE Stock Holding History

20/20 Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$289K	Buy	7,376 +91	+1%	+$3.54K	0.07%	134
2021 Q1	$264K	Sell	7,285 -685	-9%	-$24.3K	0.08%	138
2020 Q4	$279K	Buy	7,970 +608	+8%	+$22.3K	0.08%	139
2020 Q3	$256K	Buy	7,362 +897	+14%	+$31.4K	0.1%	129
2020 Q2	$236K	Buy	+6,465	New	+$220K	0.09%	123

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

20/20 Capital Management's PFE Position: Q2 2021 in Review

20/20 Capital Management increased its Pfizer (PFE) stake by 1.2% in Q2 2021, buying an estimated $3.54K and bringing the position to 7,376 shares worth $289K. The position accounts for 0.07% of the portfolio, ranked #134.

20/20 Capital Management first reported a position in PFE in Q2 2020 and has held it in 5 quarters since. 2,734 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

20/20 Capital Management held 7,376 shares of Pfizer worth $289K as of Q2 2021.
20/20 Capital Management bought 91 Pfizer shares in Q2 2021, an estimated $3.54K.
Pfizer made up 0.07% of 20/20 Capital Management's portfolio in Q2 2021, its #134 holding.
20/20 Capital Management first reported a position in Pfizer in Q2 2020 and has held it in 5 quarters since.
2,734 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on 20/20 Capital Management's 13F filing for Q2 2021, filed 12 Jul 2021.